After emergency approval: BioNTech and Pfizer shares preliminarily friendly: 90-year-old receives first BioNTech / Pfizer corona vaccination in Great Britain | message
Shares in this article
Margaret Keenan was vaccinated on Tuesday at the University Hospital in Coventry, the British health service NHS announced.
Last week, Great Britain became the first country in the world to grant the Mainz-based pharmaceutical company BioNTech and its US partner Pfizer emergency approval for their corona vaccine. Four million vaccine doses are expected to arrive in the country this year – London has ordered a total of 40 million vaccine doses. Products from domestic manufacturers are already in use in China and Russia.
Nursing home residents, medical staff, the elderly and those at risk for health should be the first to be vaccinated. According to the government, it is the largest vaccination campaign in the history of Great Britain.
“I feel so privileged to be the first person to be vaccinated against COVID-19,” Keenan told the UK news agency, PA. She is looking forward to spending time with her family and friends in the New Year, after being mostly alone this year. Keenan urged her compatriots to get vaccinated too: “If I can get them at 90, so can you.”
BioNTech shares were listed on Tuesday in pre-market NASDAQ trading at 0.28 percent up at 126.95 US dollars, while Pfizer shares on the NYSE fell 0.22 percent to 41.35 US dollars goes up.
/ cmy / DP / jha
More news about Pfizer Inc.
Image Sources: Pavlo Gonchar / SOPA Images / LightRocket via Getty Images